R. Ando, Yusaku Amano, Hideo Nakamura
Jun 15, 2006
Citations
0
Influential Citations
9
Citations
Quality indicators
Journal
Bioorganic & medicinal chemistry letters
Abstract
Novel kazusamycin A derivatives were designed in the viewpoint of decrease of reactivity at the alpha,beta-unsaturated delta-lactone moiety against Michael-type addition. Although 25-30 steps were required for the synthesis of each compound, their syntheses were achieved. Cytotoxicity against HPAC cell line was evaluated, and two of them exhibited comparable potency to kazusamycin A. Hepatic toxicity of these designed compounds was much lower than that of kazusamycin A.